Md. Moaz Ahmed Asif

Md. Moaz Ahmed Asif

Auto-generated profile, based on publicly available information

Md. Moaz Ahmed Asif

Department of Pharmacy, Faculty of Science and Engineering, University of Information Technology and Sciences, Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
MAMd. Moaz Ahmed Asif
Md. Moaz Ahmed Asif
SLSusmita Roy Lisa
Susmita Roy Lisa
NQNazmul Qais
Nazmul Qais
The chirality introduced at the C1 position of 1-substituted-1,2,3,4-tetrahydroisoquinolines, obtained by four methods of enantioselective reduction of 1-substituted-3,4-dihydroisoquinolines, are vital for various biological activities.

18 September 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
MAMd. Moaz Ahmed Asif
Md. Moaz Ahmed Asif
SLSusmita Roy Lisa
Susmita Roy Lisa
NQNazmul Qais
Nazmul Qais
The 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indoles or tetrahydro-β-carbolines (THβCs) are tricyclic compounds that are found in various natural sources that exhibit a wide range of important pharmacological activities. Chiral 1-substituted-THβCs, which have an asymmetric center at C1, have attained significant interest due to their possible Monoamine Oxidase (MAO) inhibitory activity, benzodiazepine receptor binding activity, and antimalarial effectiveness against chloroquine-resistant Plasmodium falciparum. This review highlights and summarizes various novel stereoselective approaches to introduce chirality at the C1 position of 1-substituted-THβCs in good yield and enantiomeric excess (ee) or diastereomeric excess (de). These methods include the Pictet–Spengler reaction, chiral auxiliary, Asymmetric Transfer Hydrogenation (ATH) with chiral catalysts, asymmetric addition reaction, and enzymatic catalysis. The syntheses of chiral THβCs are reviewed comprehensively, emphasizing their role in drug development from 1977 to 2024.

1 January 2025 in BioMed Research International
Verified
Journal Article
Open access
Farzana Akter MunnyFarzana Akter Munny
Farzana Akter Munny
MIMehedi Islam
Mehedi Islam
MAMahafuza Akter
Mahafuza Akter
MFMushtahsin Ferdousi
Mushtahsin Ferdousi
MAMoaz Ahmed Asif
Moaz Ahmed Asif
BBBaisakhi Banerjee
Baisakhi Banerjee
Background: Justicia gendarussa is a branched shrub spread across Indian, Sri Lankan, and Malaysian forests. It has been widely used across many countries to treat asthma, rheumatism, colics in children, eczema, and HIV. The study goal was to investigate the phytoconstituents from J. gendarussa and to discover its therapeutic potential against various disease conditions. Methods: The plant sample was collected, dried, and grinded into coarse powder which was then soaked in methanol for 2 weeks. After the maceration process, the crude methanolic extract was subjected to solvent–solvent partitioning into four different fractions: n‐hexane soluble fraction (HSF), dichloromethane soluble fraction (DMSF), ethyl acetate soluble fraction (EASF), and aqueous fraction (AQF). DMSF was chemically evaluated through chromatographic separation, and all the fractions including the crude methanolic extracts were assessed for their potential pharmacological activities against pain, oxidative stress, hyperglycemia, diarrhea, and microbes following standard protocols. Results: Chemical investigation results in the isolation of lupeol, β ‐sitosterol, and 1‐monostearin. The structures of the compounds were elucidated through meticulous NMR spectroscopic analysis. In a DPPH free radical scavenging assay, prominent action was noticed by EASF, with a median inhibition concentration (IC 50 ) of 24.207 g/mL in comparison to the BHT with an IC 50 value of 23.159 g/mL. In central analgesic activity, all the results were highly significant, with the highest (233.47%) time elongation in comparison to the control, observed after 90 min at 600 mg/kg b.w. and maximum peripheral analgesic activity of 61.96% was found at a dose of 600 mg/kg b.w. Two test doses (600 and 400 mg/kg b.w.) demonstrated substantial hypoglycemic and antidiarrheal effects that became more pronounced over time. The isolated compounds demonstrated impressive binding scores when interacting with glutathione reductase (3GRS), mu‐opioid receptor (MOR), kappa opioid receptor (KOR), and glucose transporter 3 (GLUT 3) receptors. However, their performance was notably lacking in terms of binding with cyclooxygenase‐2 (COX‐2) and dihydrofolate reductase (DHFR) receptors. Conclusion: Three isolated phytochemicals demonstrate promising binding affinities with the receptor molecules that support the pharmacological findings of this study. However, additional research needs to be conducted to isolate more phytoconstituents and affirm the pharmacological potential of J. gendarussa .